Department of Clinical and Hospital Pharmacy, College of Pharmacy, Taibah University, Al Madinah Al Munawarah 30001, Saudi Arabia.
Department of Pharmacognosy and Pharmaceutical Chemistry, College of Pharmacy, Taibah University, Al Madinah Al Munawarah 30001, Saudi Arabia.
Nutrients. 2022 Dec 15;14(24):5329. doi: 10.3390/nu14245329.
Vitamin D is among the increasingly consumed dietary supplements during the COVID-19 pandemic. It plays a regulatory role in the immune system and moderates the renin-angiotensin system, which is implicated in infection pathogenesis. However, the investigation of serum levels of vitamin D3 forms and their relative ratios in COVID-19 patients is worth investigation to understand the impacts of disease severity. Hence, we investigated the serum levels of vitamin D3 (cholecalciferol) and its metabolites (calcifediol and calcitriol), in addition to their relative ratios and correlations with angiotensin-converting enzyme 2 (ACE2), interleukin-6 (Il-6), and neutrophil-lymphocyte ratio (NLR) in COVID-19 patients compared with healthy controls. Oropharyngeal specimens were collected from the study subjects for polymerase chain reaction testing for COVID-19. Whole blood samples were obtained for blood count and NLR testing, and sera were used for the analysis of the levels of the vitamin and its metabolites, ACE2, and IL-6. We enrolled 103 patients and 50 controls. ACE2, Il-6, and NLR were significantly higher in the patients group (72.37 ± 18.67 vs. 32.36 ± 11.27 U/L, 95.84 ± 25.23 vs. 2.76 ± 0.62 pg/mL, and 1.61 ± 0.30 vs. 1.07 ± 0.16, respectively). Cholecalciferol, calcifediol, and calcitriol were significantly lower in patients (18.50 ± 5.36 vs. 29.13 ± 4.94 ng/mL, 14.60 ± 3.30 vs. 23.10 ± 3.02 ng/mL, and 42.90 ± 8.44 vs. 65.15 ± 7.11 pg/mL, respectively). However, their relative ratios were normal in both groups. Levels of the vitamin and metabolites were strongly positively, strongly negatively, and moderately negatively correlated with ACE2, Il-6, and NLR, respectively. COVID-19 infection severity is associated with a significant decrease in vitamin D3 and its metabolites in a parallel pattern, and with a significant increase in ACE2, Il-6, and NLR. Higher levels of vitamin D and its metabolites are potentially protective against severe infection.
在 COVID-19 大流行期间,维生素 D 是越来越多被消费的膳食补充剂之一。它在免疫系统中发挥调节作用,并调节肾素-血管紧张素系统,该系统与感染发病机制有关。然而,研究 COVID-19 患者血清中维生素 D3 形式及其相对比值值得调查,以了解疾病严重程度的影响。因此,我们研究了 COVID-19 患者与健康对照组相比,血清中维生素 D3(胆钙化醇)及其代谢物(骨化二醇和骨化三醇)的水平,以及它们与血管紧张素转换酶 2(ACE2)、白细胞介素 6(Il-6)和中性粒细胞-淋巴细胞比值(NLR)的相对比值和相关性。我们从研究对象的口咽标本中采集聚合酶链反应检测 COVID-19。采集全血样本进行血常规和 NLR 检测,采集血清用于分析维生素及其代谢物、ACE2 和 Il-6 的水平。我们纳入了 103 例患者和 50 例对照。患者组的 ACE2、Il-6 和 NLR 显著升高(72.37±18.67 与 32.36±11.27 U/L、95.84±25.23 与 2.76±0.62 pg/mL 和 1.61±0.30 与 1.07±0.16)。胆钙化醇、骨化二醇和骨化三醇在患者中显著降低(18.50±5.36 与 29.13±4.94 ng/mL、14.60±3.30 与 23.10±3.02 ng/mL 和 42.90±8.44 与 65.15±7.11 pg/mL)。然而,两组的相对比值均正常。维生素及其代谢物的水平与 ACE2、Il-6 和 NLR 分别呈强烈正相关、强烈负相关和中度负相关。COVID-19 感染的严重程度与维生素 D3 及其代谢物呈平行下降趋势显著相关,而 ACE2、Il-6 和 NLR 则显著升高。较高水平的维生素 D 及其代谢物可能对严重感染具有保护作用。